Your browser doesn't support javascript.
loading
What Should the Goals Be for Diverse Recruitment in Alzheimer Clinical Trials?
Grill, Joshua D; Sperling, Reisa A; Raman, Rema.
Afiliação
  • Grill JD; Institute for Memory Impairments and Neurological Disorders, Department of Psychiatry and Human Behavior, Department of Neurobiology and Behavior, University of California, Irvine.
  • Sperling RA; Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School, Boston.
  • Raman R; Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego.
JAMA Neurol ; 79(11): 1097-1098, 2022 11 01.
Article em En | MEDLINE | ID: mdl-35969392
This Viewpoint discusses why it's important for Alzheimer clinical trials to be inclusive and enroll diverse populations that include underrepresented racial, ethnic, and sociocultural groups.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Idioma: En Ano de publicação: 2022 Tipo de documento: Article